पदोन्नति कार्यक्रम Indivior PLC
उन्नत शेड्यूल
सरल ग्राफ
कंपनी के बारे में Indivior PLC
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. अधिक जानकारीIPO date | 2014-12-29 |
---|---|
ISIN | GB00BN4HT335 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 12.24 |
Дивиденд ао | 0.475 |
Сайт | https://www.indivior.com |
Цена ао | 8.71 |
प्रति दिन मूल्य परिवर्तन: | +0.487% (12.32) |
---|---|
प्रति सप्ताह मूल्य परिवर्तन: | +6.17% (11.66) |
प्रति माह मूल्य परिवर्तन: | +9.27% (11.33) |
3 महीने में कीमत में बदलाव: | +23.31% (10.04) |
छह महीने में कीमत में बदलाव: | -18.93% (15.27) |
प्रति वर्ष मूल्य परिवर्तन: | -18.93% (15.27) |
3 वर्षों में मूल्य परिवर्तन: | +1 792.97% (0.654) |
5 वर्षों में मूल्य परिवर्तन: | +12 959.07% (0.0948) |
10 वर्षों में मूल्य परिवर्तन: | 0% (12.38) |
वर्ष की शुरुआत से मूल्य परिवर्तन: | +18.41% (10.455) |
|
बहुत मूल्यवान समझना
|
क्षमता
|
|||||||||||||||||||||||||||||||||||||
लाभांश
|
कर्तव्य
|
विकास का आवेग
|
संस्थानों | आयतन | शेयर करना, % |
---|---|---|
Two Seas Capital LP | 13670312 | 9.96 |
Scopia Capital Management LP | 8311367 | 6.06 |
Vanguard Group Inc | 5846354 | 4.26 |
Goldman Sachs Group Inc | 5683038 | 4.14 |
FMR, LLC | 5498087 | 4.01 |
Artemis Investment Management LLP | 3127399 | 2.28 |
Bank of America Corporation | 2701855 | 1.97 |
Polar Capital Holdings PLC | 2621150 | 1.91 |
Acadian Asset Management. LLC | 2281179 | 1.66 |
Liontrust Investment Partners LLP | 1995889 | 1.45 |
ETF | शेयर करना, % | वर्ष के लिए लाभप्रदता, % | लाभांश, % |
---|---|---|---|
Schwab International Small-Cap Equity ETF | 0.05297 | 10.07 | 3.20638 |
![]() |
0.05 | 9.39 | 3.09932 |
Dimensional International Small Cap ETF | 0.03912 | 5.69 | 3.34747 |
Avantis International Small Cap Value ETF | 0.03727 | 14.36 | 4.23496 |
Avantis International Equity ETF | 0.01813 | 6.46 | 3.80856 |
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF | 0.01806 | 2.77 | 3.5165 |
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund | 0.01219 | 5.17 | 3.85434 |
SPDR Portfolio Europe ETF | 0.00943 | 8.94 | 3.66537 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.00881 | 13.06 | 3.62488 |
Dimensional International Core Equity 2 ETF | 0.00651 | 6.52 | 3.69996 |
![]() |
0.00638 | 5.29 | 3.28401 |
Dimensional International Core Equity Market ETF | 0.00363 | 13.09 | 3.48343 |
SPDR Portfolio MSCI Global Stock Market ETF | 0.00137 | 17.99 | 2.19607 |
पर्यवेक्षक | नौकरी का शीर्षक | भुगतान | जन्म का साल |
---|---|---|---|
Mr. Mark Crossley | CEO & Executive Director | 2.34M | |
Mr. Ryan Preblick | CFO & Executive Director | 1.14M | |
Dr. Christian Heidbreder | Chief Scientific Officer | N/A | |
Mr. Jason Thompson | Vice President of Investor Relations | N/A | |
Ms. Cynthia Cetani | Chief Integrity & Compliance Officer | N/A | |
Mr. Jeffrey W. Burris | Chief Legal Officer | N/A | 1972 (53 वर्ष) |
Mr. Jon Fogle | Chief Human Resources Officer | N/A | |
Mr. Richard Simkin | Chief Commercial Officer | N/A | |
Mr. Hillel West | Chief Manufacturing & Supply Officer | N/A | |
Mr. Vishal Kalia | SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer | N/A |
पता: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.indivior.com
वेबसाइट: https://www.indivior.com